File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients

TitleA phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients
Authors
Issue Date2021
Citation
Investigational New Drugs, 2021 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/308389
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.contributor.authorCheng, PNM-
dc.contributor.authorChiu, WYJ-
dc.contributor.authorKwok, GW-
dc.contributor.authorLeung, RCY-
dc.contributor.authorLiu, AM-
dc.contributor.authorCheung, TT-
dc.contributor.authorNg, CT-
dc.date.accessioned2021-12-01T07:52:41Z-
dc.date.available2021-12-01T07:52:41Z-
dc.date.issued2021-
dc.identifier.citationInvestigational New Drugs, 2021-
dc.identifier.urihttp://hdl.handle.net/10722/308389-
dc.languageeng-
dc.relation.ispartofInvestigational New Drugs-
dc.titleA phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients-
dc.typeArticle-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.emailChiu, WYJ: jwychiu@hku.hk-
dc.identifier.emailCheung, TT: cheung68@hku.hk-
dc.identifier.emailNg, CT: ctctng@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.authorityChiu, WYJ=rp01917-
dc.identifier.authorityCheung, TT=rp02129-
dc.identifier.doi10.1007/s10637-021-01178-3-
dc.identifier.scopuseid_2-s2.0-85118563739-
dc.identifier.hkuros330525-
dc.identifier.isiWOS:000714494000001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats